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The production of reactive oxygen species (ROS) may promote immunosenescence if not counterbalanced by the antioxidant
systems. Cell membranes, proteins, and nucleic acids become the target of ROS and progressively lose their structure and
functions. This process could lead to an impairment of the immune response. However, little is known about the capability of
the immune cells of elderly individuals to dynamically counteract the oxidative stress. Here, the response of the main
lymphocyte subsets to the induced oxidative stress in semisupercentenarians (CENT), their offspring (OFF), elderly controls
(CTRL), and young individuals (YO) was analyzed using flow cytometry. The results showed that the ratio of the ROS levels
between the induced and noninduced (I/NI) oxidative stress conditions was higher in CTRL and OFF than in CENT and YO, in
almost all T, B, and NK subsets. Moreover, the ratio of reduced glutathione levels between I/NI conditions was higher in OFF
and CENT compared to the other groups in almost all the subsets. Finally, we observed significant correlations between the
response to the induced oxidative stress and the degree of methylation in specific genes on the oxidative stress pathway.
Globally, these data suggest that the capability to buffer dynamic changes in the oxidative environment could be a hallmark of
longevity in humans.
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1. Introduction
Immunosenescence is characterized by age-associated
changes in cell phenotype and function that ultimately leads
to a general impairment of the immune response [1]. In the
innate compartment, in mice as well as in humans, a decrease
in neutrophil chemotaxis, phagocytosis, and oxidative burst
has been observed along with a decrease in natural killer
(NK) cells and macrophage cell functions [2, 3]. Changes in
the acquired immunity during ageing are driven by the
thymic involution, leading to a decreased production of naïve
T cells capable of replenishing the peripheral pool [4].
Furthermore, homeostatic mechanisms as well as persistent
infections (i.e., cytomegalovirus) push memory T cells
towards several rounds of replication during the ageing pro-
cess [5–7]. Once reached the replicative senescence, these
cells show energy, resistance to apoptosis, and changes in
cytokine production [8]. Moreover, the impairment of the
immune function during the ageing process can be even pro-
moted by its inability to restore a proper balance between
prooxidant, such as reactive oxygen species (ROS), and anti-
oxidant molecules, such as the enzymes superoxide dismut-
ase and catalase or the reducing agent glutathione (GSH).
This condition is commonly defined as oxidative stress [9,
10]. ROS are continuously produced in the mitochondria as
a result of the reduction of a small percentage of molecular
oxygen by leaked electrons in the electron transporting chain
or are produced enzymatically by the NADPH oxidase,
mediating the respiratory burst in phagocytes. Other sources
of ROS include the xanthine oxidase or the nitric oxide syn-
thase pathways as well as environmental ultraviolet or ioniz-
ing radiation [11]. ROS play an important role in the
immune system other than the respiratory burst, participat-
ing in the T, B, NK, and dendritic cell signaling or coordinat-
ing the cytokine production [12–14]. Nevertheless, ROS
mediate detrimental effects to different cellular components
if not properly counterbalanced by the antioxidant system
within the cell. Such effects include lipid peroxidation,
DNA oxidative damage, and protein modifications like glu-
tathionylation and carbonylation [15, 16]. As an example,
in the immune system, it has been shown that the oxidative
modifications of proteins can alter the tertiary structure of
the self-molecules, thus representing a risk factor for the
development of autoimmune reactions [17, 18]. Moreover,
oxidative changes can impair the proteasome functions,
resulting in an uncorrected processing of peptides for T cell
presentation by MHC molecules [19]. Immunosenescence
per se (thymic involution, memory T cell expansion, and rep-
licative senescence) and oxidative stress are key stimuli for
fueling the low grade, persistent, and systemic inflammatory
status, known as “inflammaging” [20], that is one of the pil-
lars of the ageing process and strongly contributes to the
pathogenesis of the main age-related diseases in humans. In
this framework, centenarians who have survived, escaped,
or delayed the onset of major age-related diseases achieving
the extreme limits of the human life-span appear to have
reached a balanced status between the inflammaging and
the so called anti-inflammaging; that is, the process, involv-
ing molecules and their related pathways, aimed to control
and modulate the inflammation and/or the oxidative stress
[21]. Data in literature show that centenarians have less
amounts of plasma oxidative stress markers [22, 23] or
increased amounts of antioxidant vitamins [24]. However,
there is a lack of experimental data in human models on
the oxidative stress measured directly in the cells, and espe-
cially in white blood cells, from centenarians. In fact, such
determinations were performed using cells from elderly sub-
jects who turned 95 yo as a maximum [25–27]. Moreover,
these studies performed mainly the oxidative stress determi-
nation at the baseline, that is, without inducing the ROS pro-
duction. As the organisms face dynamic changes of the
oxidative environment [28], we questioned if the capability
of a cell in resisting the induced oxidative stress could be a
hallmark of an efficient anti-inflammaging and thus of
healthy ageing and longevity. To the best of our knowledge,
only limited data on the response to induced oxidative stress
in centenarians is available in literature [29]. In this paper, in
order to provide further evidence to this concept, we per-
formed an in-depth cell immunophenotyping and oxidative
stress analysis by means of polychromatic flow cytometry
(PFC) in a cohort of semisupercentenarians (CENT), elderly
controls (CTRL), and young (YO) individuals. Moreover, the
present analysis includes cells from centenarians’ offspring
(OFF), individuals representing an informative model to
identify trajectories of healthy aging and their determinants
(genetic and environmental). PFC was used to analyze the
response to induced oxidative stress as ROS and GSH relative
fluorescence in the main subsets of T, B, and NK cells. The
phenotypic changes were also evaluated by PFC in order to
illustrate the ongoing process of immunosenescence in such
cohort. DNA methylation profile of a list of genes involved
in the response to oxidative stress was also analyzed, in order
to determine whether changes in the ability to cope with oxi-
dative stress may be related to epigenetic reasons.
2. Methods
2.1. Subject Cohort. The subjects described in this paper
(CENT n = 7: 3 males (M)/4 females (F), median age/range
106 yrs/105–107 yrs; OFF n = 6: 3M/3F, median age/range
72 yrs/59–85 yrs; CTRL n = 7: 4M/3F, median age/range
72 yrs/59–77 yrs; and YO n = 7, 3M/4F, median age/range
35 yrs/25–37 yrs) were recruited all in Bologna and were part
of a larger cohort described elsewhere [30]. The study proto-
col was approved by the Ethical Committee of Saint Orsola-
Malpighi University Hospital (Bologna, Italy). Informed
written consent for the participation was obtained at the time
of blood withdrawal.
2.2. PBMC Separation.Diluted heparinized blood in PBS was
carefully layered on Ficoll-Hypaque and centrifuged for
20min at 600g. After removal of platelets by centrifuging
for 10min at 200g, PBMCs were resuspended in the frozen
medium (FBS/10% DMSO), stored at −80°C for 24 hours
and then transferred in liquid nitrogen until used.
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2.3. Flow Cytometry. Cells were thawed in warm Iscove Mod-
ified Dulbecco’s Medium (IMDM), centrifuged at 200g for
5min, and resuspended in 100μl of IMDM. Briefly, PBMCs
(2 tubes for T cell and 2 for B/NK detection) were incubated
in the presence or absence of ROS inducer tert-butyl-
hydroperoxide (TBHP) for 30min at 37°C in 5% CO2,
according to the manufacturer’s instructions (Invitrogen,
Carlsbad, CA, USA). Then, fluorescent probes for GSH
(Thiol Tracker, TT, Invitrogen, ex: 405 nm, em: 525nm)
and ROS (CellROX green, Invitrogen, ex: 508 nm, em:
525nm, specific for H2O2 and superoxide anion) were added
at a final concentration of 5μM and 500nM, respectively.
Cells were incubated for additional 30min at 37°C in 5%
CO2. 50μl of mixtures of mAbs targeting the antigens for
specific T, B, and NK subsets was then added to the respective
tube for 15min. Mix for T cells includes the following
mAbs all purchased from Beckman Coulter (Bree, CA,
USA): anti-CD25-phycoerhytrin (PE), CD45RO-PE-Texas
Red, CD3-PE-cyanine 7 (Cy7), CD45-Alexa 700, and CD4-
allophycocyanin- (APC-) Cy7. Anti-CCR7-peridinin chloro-
phyll-Cy5.5, CD127-Alexa 647, and anti-CD8-BUV395 were
acquired from Becton Dickinson, (Franklin Lakes, NJ, USA).
Mix for B and NK cells includes anti-CD16-PE, anti-
CD38-PE-Texas Red, anti-CD27 PE-Cy5.5, anti-CD3-PC7,
anti-CD56-APC, anti-CD45 APC-Alexa 700, and CD20-
APC-Cy7 purchased from Beckman Coulter and CD19-
BUV395 from Becton Dickinson. Samples were then diluted
by adding 300μl of PBS and acquired by means of a LSORP
Fortessa equipped with 5 laser lines (355 nm, 405nm,
488nm, 561nm, and 640nm) and 18 photomultipliers
(PMTs). Dead cells were excluded using a viability dye (Live
Dead, Invitrogen). All the reagents were titered according the
internal SOPs. Moreover, to ensure consistent and reproduc-
ible results, we used the 8-peak Rainbow Beads (Spherotech,
Lake Forest, IL, USA) as a fluorescent calibrator allowing us
to trace the laser/PMT performance across the independent
experimental runs. PBMC subsets were identified by a hierar-
chical gating strategy considering the shared (or not) CD
antigens among the different populations. Data files were
saved in the FCS 3.0 format and analyzed offline using the
Batch Analysis function of the FCS Express 5.0 package (De
Novo software, Glendale, CA, USA) allowing to export all
percentages and fluorescence values in Excel format. The
percentage of a given cell subset was referred to the parental
gate (i.e., CD4 naïve in the CD4 gate or Tregs in CD4 mem-
ory gate). The level of ROS or GSH at the baseline was eval-
uated by the median fluorescence intensity (MFI) of the
relative probe, whereas the response to induced oxidative
stress was calculated as the ratio of MFIs of ROS (or GSH)
between the I and NI conditions.
2.4. Methylation Profile. Whole-genome DNA methylation
profile of PBMCs from the entire cohort has been described
previously [30]. Briefly, genomic DNA was extracted from
PBMCs with the AllPrep DNA/RNA/protein kit (QIAGEN,
Hilden, Germany) and it was treated with sodium bisul-
phite using the EZ-96 DNA Methylation Kit (Zymo
Research, Irvine, CA). Genome-wide DNA methylation level
was assessed using the Infinium HumanMethylation450
BeadChip (Illumina, San Diego, CA) following the manu-
facturer’s instructions, and the arrays were scanned by
HiScan (Illumina).
2.5. Statistical Analysis. Differences among groups in T, B,
and NK subsets for cell percentages or MFI of ROS and
GSH were assayed using the nonparametric Kruskal-Wallis
one-way analysis of variance followed by Dunn’s posttest.
Correlations between cell percentage and age or between
ROS MFI ratios and the degree of methylation were assayed
using Spearman correlation. Prism 5.0 was used for both
analyses (GraphPad, La Jolla, CA, USA).
For DNA methylation analysis, beta values were
extracted using minfi Bioconductor package. The differences
among CENT, CTRL, and OFF were assessed by ANOVA
with R software.
3. Results
3.1. Percentages of PBMC Subsets across the Age Groups.
As expected, correlation analysis showed a significant
age-related decrease in the percentage of naïve subsets
both in CD4 and CD8 T lymphocytes (p = 0 0014 and p <
0 0001, resp.). Conversely, a significant age-related increase
in CD4 central memory (Cm; p = 0 01), effector memory
(Em; p < 0 0001), and regulatory T cells (Tregs; p = 0 03) as
well as inCD8Emand terminally differentiated effectormem-
ory (TeMRA) cells was observed (p < 0 0001; Figures 1(a)
and 1(b)). Analysis of variance (ANOVA) showed signifi-
cant differences in the percentages of CD4 and CD8 sub-
sets (except for CD4 and CD8 Cm and Tregs) between
YO and CENT. No differences between OFF and CTRL
in the different subsets were appreciated (Figures 1(a)
and 1(b)). When considering B and NK cells, correlation
analysis showed a significant inverse correlation with the
age of the CD56bright subset, whereas no age correlation
in B or NK CD56dim cells was observed (Figure 2).
ANOVA showed statistically significant differences in B
and NK CD56dim percentages across the age groups. Per-
centages of B cells in CTRL and OFF were significantly
higher than those in CENT. Notably, CENT showed sim-
ilar percentages of B lymphocytes compared with YO.
Lastly, CTRL and OFF showed lower percentages of NK
CD56dim cells compared with YO and CENT. Likewise,
B cells, CENT and YO showed similar percentages of NK
CD56dim (Figure 2).
3.2. Oxidative Stress and GSH Content at the Baseline in
PBMC Subsets. The levels of ROS and GSH in noninduced
(NI) condition were determined by means of the fluorescent
probes. No significant differences among the age groups were
observed, although a tendency towards higher levels of ROS
in the YO was observed in several subsets (see Table S2).
Results of GSH analysis showed a lower GSH level in OFF
and CENT compared with YO and CTRL in all PBMC
subsets considered, although ANOVA did not show signif-
icant differences among the age-groups (Figures 3 and 4
and Table S4).
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Figure 1: Continued.
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Figure 1: (a) Correlation between age and cell percentage and ANOVA for the cell percentage among the age groups in CD4 subsets. Overall
ANOVA p values are as follows: CD4 naïve: p = 0 03; CD4 Cm: p = 0 14; CD4 Em: p = 0 0012; and Treg: p = 0 10. Significant results of Dunn’s
posttest are illustrated on the plots. (b) Correlation between age and cell percentage and ANOVA for the cell percentage among the age groups
in CD8 subsets. Overall ANOVA p values for CD8 subsets are as follows: CD8 naïve: p < 0 0001; CD8 Cm: p = 0 28; CD8 Em: p = 0 0004; and
CD8 TeMRA: p = 0 0014. Significant results of Dunn’s posttest are illustrated on the plots.
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3.3. Response of the PBMC Subsets to Induced Oxidative
Stress. To investigate the hypothesis that a different response
to induced oxidative stress can be detected among the age
groups, the ratio of ROS and GSH MFI between the induced
(I) and NI oxidative stress conditions in the PBMC subsets
was calculated (see Tables S3 and S5 for ROS and GSH
MFI values in I condition). ANOVA showed significant over-
all differences in the CD4 and CD8 naïve subsets (p = 0 0096
and p = 0 03, resp.) and a trend for the CD8 TeMRA and NK
subsets (p = 0 0571 and p = 0 07 for both NK CD56bright/
dim, resp.; see Figures 5 and 6 and Table 1). Higher ROS I/
NI MFI ratios were observed for CTRL and OFF in almost
all the T, B, and NK subsets in comparison with YO and
CENT, although such differences were not statistically signif-
icant at an alpha level of 5% (only in CD4 naïve, ROS I/NI
ratio was significantly lower in YO compared to CTRL and
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Figure 2: Correlation between age and percentage and ANOVA for the percentage among the age groups in B and NK subsets. Overall
ANOVA p values for B cells: p = 0 002; NK CD56bright: p = 0 06; and NK CD56dim: p = 0 007. Significant results of Dunn’s posttest are
illustrated on the plots.
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CENT; see Figures 5 and 6 and Table 1). When we analyzed
the GSH I/NI MFI ratios, ANOVA showed significant overall
differences in CD4/8 naïve, CD4/8 Cm, CD4 Em, Treg, and B
lymph. In general, a trend for increasing median values was
observed across the 4 groups in almost all subsets, CENT
and OFF showing the highest values. Notably, in CD4/8
naïve, CD4/8 Cm, CD4 Em, and Tregs, Dunn’s posttest
showed a significant difference between YO and CENT,
whereas significant differences between CTRL and YO were
detected in CD4 naïve and B lymphocytes (see Figures 7
and 8 and Table 2).
3.4. Correlation between the Response to Induced Oxidative
Stress and the Degree of Methylation of Oxidative Stress-
Related Genes. Finally, we evaluated if the differences in the
response to induced oxidative stress described in the above
paragraph could be related to epigenetic changes among the
4 groups. To this aim, we first considered the DNA methyla-
tion status of a list of genes involved in the response to oxida-
tive stress (see Table S1) in a dataset including 47 CTRL, 63
OFF, and 82 CENT subjects. Several CpG sites showed signif-
icant DNA methylation differences in the three comparisons
CENT versus CTRL, CENT versus OFF, and CTRL versus
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Figure 3: ANOVA for the levels of GSH expressed as MFI of the specific probe (Thiol Tracker, TT) among the age groups in CD4 and CD8
subsets. Overall ANOVA p values for CD4 subsets are as follows: CD4 naïve: p = 0 13; CD4 Cm: p = 0 16; CD4 Em: p = 0 20; and Treg:
p = 0 15. Overall ANOVA p values for CD8 subsets are as follows: CD8 naïve: p = 0 38; CD8 Cm: p = 0 23; CD8 Em: p = 0 28; and CD8
TeMRA: p = 0 50.
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Figure 4: ANOVA for the levels of GSH expressed as MFI of the specific probe (Thiol Tracker, TT) among the age groups in B and NK
subsets. Overall ANOVA p values for B cells: p = 0 50; NK CD56bright: p = 0 35; and NK CD56dim: p = 0 07.
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OFF (ANOVA p value< 0.05) (File S1). Several genes exhib-
ited 2 or more adjacent differentially methylated CpG sites in
the CENT versus CTRL and CENT versus OFF comparisons,
suggesting a general epigenetic remodeling of these loci in the
analyzed groups. These genes include GGT1, GGT6, GPX5,
GPX6, GSTA 3-4, GSTM2, and LDHD (see Figures S1 and
S2 sample plots). As a further step, we selected from the
DNA methylation dataset the samples analyzed for the
induced oxidative stress response (3 CTRL, 6 OFF, and 7
CENT) and correlated the degree of methylation of the
abovementioned genes with the ROS I/NI ratio. Impor-
tantly, in this subcohort, the methylation profiles were
comparable to those found in the whole cohort (see Figure
S4 for an exemplative plot related to the GGT1 gene). As
the methylation profile was assessed using PBMCs, we rea-
nalyzed the ROS I/NI ratio gathering all the lymphocytes
subsets together, including the monocyte population (per-
centage varying from 1 to 10% of the samples). The ROS I/
NI ratio in CENT tended to be lower than in OFF and CTRL
(Figure S3 and Table S6), confirming the above described
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Figure 5: ANOVA for the ratios of the levels of ROS (expressed as MFI values of the ROS probe) between the I and NI oxidative stress
conditions in CD4 and CD8 subsets among the age groups. See Table 1 for overall ANOVA p values. Significant results of Dunn’s posttest
are illustrated on the plots.
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Figure 6: ANOVA for the ratios of the levels of ROS (expressed as MFI values of the ROS probe) between the I and NI conditions in B and NK
subsets among the age groups. See Table 1 for overall ANOVA p values.
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results on separated cell populations, although the differences
were not statistically significant according to ANOVA test.
This was probably due to the small sample size of the CTRL
group, as methylation data were available only for 3 subjects
analyzed with flow cytometry. Notwithstanding, Spearman
correlation between the ROS I/NI ratio and the DNA meth-
ylation resulted significant for several CpG sites within
GGT1 and LDHD genes (positive correlation) and GSTM2
(negative correlation) (Figure 9).
4. Discussion
In this paper, by means of PFC, we assessed the differences in
the response towards induced oxidative stress in the main
subsets of PBMC among the age groups, enumerating at the
same time the relative amounts of each cell subset, in order
to describe the process of immunosenescence. Notably, we
had the opportunity to collect and analyze PBMC samples
from the centenarians’ offspring. This unique feature allowed
us to reveal the cell phenotype of subjects sharing with CENT
possible variants of genes involved in the healthy ageing and
longevity and to further compare such phenotype with the
one of their age-matched CTRL. Our data in T cell compart-
ment, both in CD4 and CD8, show an age-related decrease in
the percentage of naïve T cells and an increase in almost all
the memory T cell subsets, including Tregs. Although the
number of subjects analyzed in these cohorts was limited
(n = 27), the differences observed are highly significant and
these data are in line with the literature. Taken together,
our results consistently describe the process of thymic invo-
lution and memory inflation, especially in the effector com-
partment [31–33, 35, 36]. Notably, in almost all T cell
subsets, the percentage of cells in OFF and CTRL was compa-
rable, suggesting that the immunosenescence of the T cell
compartment follows the common age-dependent pattern,
rather than being correlated to the genetic background.
Moreover, we found increased percentages of B cells from
YO to OFF, whereas in CENT, the percentages were compa-
rable to YO. This is in contrast with previous observations in
humans, in which a decrease or no changes were observed
[31, 34]. This could be related to the decrease in CD3 T cell
percentages observed in the present study from YO to OFF,
already described in literature [31], whereas in CENT, the
percentage was similar to YO (data not shown). As the B
and CD3 gates were drawn under the same parent gate (lym-
phocyte scatter), the decrease in CD3 affected the B cell
percentage. In this case, absolute counts would have provided
more information on the amount of B cells among the
groups, but only if using whole blood with stain-lyse-no wash
methods, a condition that was not applicable in the present
study. Finally, we observed a decreased percentage of NK
CD56dim cells in CTRL and OFF, whereas in CENT, the per-
centage of such cells was similar to YO. As already suggested,
the preservation of the number and bona fide function of the
NK cytotoxic subset could represent a hallmark of healthy
ageing [31, 34]. Once the relative amount of each PBMC sub-
set in the age groups was determined, the response of such
subsets to the induced oxidative stress was investigated.
Our results showed no appreciable differences in the relative
amount of ROS at the baseline in the different PBMC subsets
among the age groups. Our results at the baseline are differ-
ent from those available in literature, showing in general an
age-related increase of the cellular oxidative stress parame-
ters [25–27]. This could be due to different factors including
the cell type investigated, the analytical methodology used,
and the source of biological material, that is, frozen PBMC.
Indeed, this represents a limitation of the study, as it has
already been shown that the freeze-thaw process can modify
the signal from ROS [27]. However, the main objective of this
study was to define the response to the dynamic changes in
the oxidative stress in subjects of different ages, rather than
a baseline. This could represent a better hallmark of healthy
ageing and at the same time offer a more reliable measure-
ment than the baseline, potentially biased by the freeze-
thaw process. Thus, we compared the ratio between the
MFI of ROS in I and NI conditions. The results showed that
CENT resists better to the induced oxidative stress compared
with OFF and YO in almost all the PBMC subsets, having a
lower ratio, in many subsets comparable to YO. Although
the post hoc comparisons failed to provide significant statis-
tical differences intergroups (possibly due to the limited
number of subjects analyzed and then to the biological vari-
ability), our data suggests that CENT may have adopted effi-
cient strategies to counteract possible sudden changes in the
redox environment. This can limit the oxidative damage and,
thus, preserve a better cellular response especially in the
immune system. Notably, these results are in line with those
obtained by Alonso-Fernández et al. measuring superoxide
anion production in stimulated (but also not stimulated)
neutrophils in young, middle-aged, and centenarian subjects
[29]. In a previous work, using different methodologies, an
age-related decreased susceptibility to the oxidative stress-
induced apoptosis in nonactivated PBMC was demonstrated
[37]. It is tempting to speculate that if, on the one hand, the
chronic exposure to ROS decreases the susceptibility to
apoptosis leading to the accumulation of particular subsets,
on the other hand, CENT may be better suited to counteract
dynamic variations in oxidative stress, preserving a better
Table 1: Ratios of the MFI values of the ROS probe between the I
and NI conditions in all the PBMC subsets among the age groups.
ROS I/NI ratio YO CTRL OFF CENT
Overall ANOVA
p value
CD4 naïve 1.500 4.858 4.040 3.155 0.0096
CD4 Cm 1.631 2.724 3.256 2.992 0.2185
CD4 Em 2.423 2.279 3.336 1.622 0.1138
Treg 1.656 1.973 1.919 1.485 0.9240
CD8 naïve 1.247 3.432 3.798 3.281 0.0370
CD8 Cm 1.340 2.524 3.051 2.793 0.1657
CD8 Em 2.440 3.701 3.647 2.429 0.1745
CD8 TeMRA 2.225 3.129 3.585 1.953 0.0571
B lymph 1.289 3.023 2.346 1.457 0.2442
NK CD56bright 2.473 7.554 5.966 5.088 0.0727
NK CD56dim 1.782 5.021 3.915 2.410 0.0747
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cellular response in such subsets. In this context, several lines
of research put efforts in defining genetic variants in oxida-
tive stress response genes that can be associated with excep-
tional longevity [38], and even more interest relies around
the epigenetic changes, such as DNA methylation, that can
underline the ageing process and be hallmarks of healthy age-
ing [39–41]. Presently, and with the limited number of sub-
jects analyzed, we showed for the first time a significant
correlation between the response to the oxidative stress in
the PBMC population and the degree of methylation in
several CpG positions of selected genes involved in the
response to oxidative stress (LDHD, GGT1, and GSTM2;
[42–44]). These findings could have relevant functional
implications, as the differential degree of methylation
could control the mRNA expression [45] leading, in turn,
to different protein levels [46]. Thus, at least from a hypo-
thetical perspective, different amount of proteins could
impact differently the oxidative stress response. For limita-
tions due to the availability of the specific PBMC samples,
we have not been able to test such hypothesis. Thus,
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Figure 8: ANOVA for the ratios of the levels of GSH (expressed as MFI values of the TT probe) between the I and NI conditions in B and NK
subsets among the age groups. See Table 2 for overall ANOVA p values. Significant results of Dunn’s posttest are illustrated on the plots.
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Figure 7: ANOVA for the ratios of the levels of GSH (expressed as MFI values of the TT probe) between the I and NI conditions in CD4 and
CD8 subsets among the age groups. See Table 2 for overall ANOVA p values. Significant results of Dunn’s posttest are illustrated on the plots.
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additional experiments are needed, in order to ascertain
whether differences in DNA methylation could be associated
with variations in the gene (and protein) expression after
dynamic changes in ROS level. In order to overcome possible
limitations due to sample availability, PFC can be used for all
the readouts, combining gene expression profiling with
immunophenotyping and oxidative stress detection [47].
This would eventually allow a precise dissection of subset-
related differences in the expression of selected genes, with-
out the need to physically separate cells by cell sorting. When
we approached the oxidative stress response from the antiox-
idant perspective, we observed an important decrease in GSH
content at baseline in almost all subsets. An age-related
decrease of GSH content has been already described in the
lymphocyte population [26, 48], and the decline has been
associated with a decrease in the γ-glutamil cysteine ligase
(GCL), an important enzyme in the GSH biosynthesis,
expression, and activity [49]. Notably, OFF showed the same
GSH level as CENT, and much lower than the CTRL group.
However, the induced oxidative stress promotes an increase
in cellular GSH content [50] and, in our experimental model,
we observed an age-related increase in GSH ratio after oxida-
tive stress induction. In particular, CENT showed the highest
fold-increase values in 6 out of 11 PBMC subsets analyzed,
whereas OFF showed a GSH fold-increase value higher than
CTRL in 8 out of 11 subsets. Strikingly, we observed a
decrease in the baseline GSH content (ratio between I/NI
condition< 1) after induction only in the YO and CTRL
groups: in CD8 naïve, CD8Cm/Em, and in NK CD56dim
subsets. This observation would suggest that CENT, consis-
tent with the smaller fold-increase observed in ROS,
promptly synthesizes and uses GSH to buffer the dynamic
changes in oxidative stress level. Moreover, this could
explain the fact that we did not observe drastic changes in
the absolute fluorescence value of GSH. On the contrary,
OFF produces GSH after oxidative stress induction but is
not capable to efficiently use it to counteract the increase
of cellular ROS. From a hypothetical point of view, we may
speculate that CENT has a reduced capability to produce
LDHD
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Figure 9: Analysis of correlation between the degree of methylation
of the CpG sites and the response to induced oxidative stress
(expressed as the ratio of MFI values of the ROS probe
between I/NI conditions) for LDHD (top), GSTM2 (middle), and
GGT1 (bottom) genes.
Table 2: Ratios of the MFI values of the GSH probe (Thiol Tracker,
TT) between the I and NI conditions in all the PBMC subsets among
the age groups.
GSH I/NI ratio YO CTRL OFF CENT
Overall ANOVA
p value
CD4 naïve 1.004 2.301 1.638 2.253 0.0050
CD4 Cm 1.019 1.833 1.660 2.482 0.0246
CD4 Em 1.150 1.736 2.063 2.513 0.0194
Treg 1.180 1.906 1.661 2.737 0.0146
CD8 naïve 0.9818 1.538 1.803 1.811 0.0295
CD8 Cm 1.086 0.9634 2.357 1.928 0.0114
CD8 Em 0.9410 1.019 2.832 2.176 0.1413
CD8 TeMRA 1.105 1.038 2.166 1.794 0.2438
B lymph 1.234 2.173 4.990 5.755 0.0171
NK CD56bright 1.207 1.712 5.077 6.949 0.1504
NK CD56dim 0.9887 0.9486 2.321 1.513 0.0913
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constitutive GSH but at the same time is more efficient in
producing and using GSH under stress conditions. In con-
trast, YO and CTRL rely on their GSH stores to counteract
the dynamic changes in the redox environment, whereas
OFF promptly triggers GSH production but, unlike the
CENT, appears not to be capable in using it to buffer the cel-
lular ROS increase. Such observations, however, need to be
confirmed in other independent cohorts of ageing subjects.
Taken together, our results suggest that, at least in cultured
PBMC, the resistance to changes in oxidative stress levels
is a characteristic of the group of subjects who reached
healthy ageing. In the immune system, this possibly implies
that CENT could maintain good cell functions in order to
efficiently fight infections. However, our observations must
be placed into a more comprehensive framework as ageing
involves complex processes shaped by genetic, epigenetic,
and environmental factors. Thus, further investigations are
needed to elucidate the mechanisms of the resistance to
oxidative stress and to evaluate possible intervention
(i.e., diet and lifestyle) to enhance such resistance in the
ageing population.
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Supplementary Materials
Table S1: list of the genes involved in response to the oxidative
stress. Figure S1: percentage of methylation of the CpG sites
throughout the GGT1 gene in the 3 ageing groups. Vertical
bars represent the standard deviation of the mean of the meth-
ylation values for each CpG site in the 3 groups. Figure S2: per-
centage of methylation of the CpG sites throughout the
GSTM2 gene in the 3 ageing groups. Vertical bars represent
the standard deviation of the mean of the methylation values
for each CpG site in the 3 groups. Figure S3: ratios of the
MFI values of the ROS probe between the I and NI conditions
in the whole PBMC population across 3 groups of ageing indi-
viduals (subcohort n = 16). Figure S4: percentage of methyla-
tion of the CpG sites throughout the GGT1 gene in the
subcohort of 16 subjects. Vertical bars represent the standard
deviation of the mean of the methylation values for each CpG
site in the 3 groups. ANOVA between the three groups (CENT
n = 7; OFF n = 6; CTRL n = 3) showed the following results:
cg25590527: p = 0 0042; q = 0 1181; cg13825083: p = 0 0406;
q = 0 1800; cg21881327: p = 0 019; q = 0 1788; cg09598276:
p = 0 0304; q = 0 1788; cg01120527: p = 0 005; q = 0 1181;
cg22123459: p = 0 003; q = 0 1181. Table S2: MFI values of
the ROS probe in the NI condition among the age groups
in the PBMC subsets. Table S3: MFI values of the ROS
probe in the I condition among the age groups in the
PBMC subsets. Table S4: MFI values of the GSH probe in
the NI condition among the age groups in the PBMC sub-
sets. Table S5: MFI values of the GSH probe in the I condi-
tion among the age groups in the PBMC subsets. Table S6:
MFI values of the ROS and GSH probes in the NI, I, and I/
NI conditions in the whole PBMC population among the
age groups. (Supplementary Materials)
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